Theriva Biologics News

Theriva Biologics | 8-K: Current report

Apr 23 07:04 ET

Theriva Biologics | 8-K: Current report

Apr 22 16:42 ET

Theriva Biologics | 8-K: Current report

Apr 16 08:05 ET

Theriva Biologics | 10-K: Annual report

Mar 25 16:26 ET

Theriva Biologics | 8-K: Current report

Mar 25 07:43 ET

Theriva Biologics | 8-K: Current report

Feb 7 08:15 ET

Theriva Biologics | 8-K: Current report

Jan 8 00:00 ET

Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Officer SHALLCROSS STEVEN A

Dec 15, 2023 16:07 ET

Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Director Wolf Jeffrey Alan

Dec 15, 2023 16:01 ET

Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Director Kraws Jeffrey J

Dec 15, 2023 16:00 ET

Theriva Biologics | 4: Statement of changes in beneficial ownership of securities-Director MONAHAN JOHN J

Dec 15, 2023 16:00 ET

Theriva Biologics: Q3 2023 Earnings Report

Nov 13, 2023 08:15 ET

Theriva Biologics | 8-K: Theriva™ Biologics Reports Third Quarter 2023 Operational Highlights and Financial Results

Nov 13, 2023 08:10 ET

Theriva Biologics | 8-K: Current report

Oct 23, 2023 07:10 ET

Theriva Biologics | 8-K: Current report

Oct 17, 2023 06:05 ET

Theriva Biologics | 8-K: Current report

Oct 3, 2023 06:06 ET

Theriva Biologics | DEFR14A: Definitive proxy statement in connection with contested solicitations

Aug 16, 2023 17:24 ET

Theriva Biologics | ARS: Annual Report to Security Holders

Aug 15, 2023 09:53 ET

Theriva Biologics | DEF 14A: Definitive information statements

Aug 14, 2023 17:11 ET

Theriva Biologics | 8-K: Current report

Aug 11, 2023 16:30 ET